Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
If 99% of people aren’t a thing, then 1% of people are. That’s like 80 million people.
Yeah, I’m not trusting an article that makes a lot of claims that are contrary to my lived experience and everything else I’ve ever read but cites nothing.